BioMarin Pharmaceutical financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$18.64M | $25.67M | $84.21M | $121.58M | $296.49M | $324.66M | $376.27M | $441.36M | $500.72M | $548.49M | $749.28M | $889.90M | $1.12B | $1.31B | $1.49B | $1.70B | $1.86B | $1.85B | $2.10B | $2.42B | $0.00M |
| GM % | Gross Margin % |
|
-188.27% | -129.93% | 10.37% | 20.25% | 50.83% | 44.24% | 42.17% | 32.39% | 21.30% | 19.20% | 22.08% | 11.58% | 21.97% | 35.10% | 32.16% | 36.95% | 38.06% | 40.46% | 45.93% | 47.85% | 0.00% |
| OM | Operating Margin |
|
0.00% | -296.28% | -51.57% | -47.12% | 13.41% | 5.06% | 1.67% | -8.09% | -18.92% | -25.63% | -19.31% | -34.83% | -23.41% | -9.41% | -10.40% | -6.15% | -4.93% | -4.03% | 2.19% | 7.11% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.08 | $-0.34 | $-0.16 | $0.34 | $0.00 | $1.75 | $-0.46 | $-0.95 | $-1.08 | $-1.35 | $-0.89 | $-0.22 | $0.42 | $0.51 | $0.93 | $1.63 | $1.33 | $1.93 | $2.08 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | -0.00% | -0.00% | -0.00% | 0.00% | 0 | 0.00% | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 |
| Sha. | Shares |
|
64.5m | 73.89m | 91.35m | 96.82m | 99.83m | 100.73m | 102.5m | 114.21m | 123.83m | 142.21m | 147.47m | 161.25m | 171.99m | 175.62m | 178.06m | 179.63m | 181.53m | 182.66m | 183.91m | 188.37m | 188.68m |
| OCF | Operating Cash Flow |
|
$-54.30M | $-59.15M | $-52.27M | $-35.03M | $-9.18M | $87.73M | $18.75M | $18.42M | $17.61M | $-57.34M | $-70.42M | $-219.50M | $-227.84M | $-8.76M | $20.21M | $48.26M | $85.37M | $304.54M | $175.90M | $159.26M | $0.00M |
| FCF | Free Cash Flow |
|
$-75.12M | $-65.64M | $-76.85M | $-57.44M | $-65.55M | $-2.07M | $-30.71M | $-54.47M | $-26.96M | $-124.76M | $-192.37M | $-449.34M | $-376.22M | $-207.98M | $-124.41M | $-96.76M | $-28.95M | $208.96M | $54.94M | $405.68M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.17 | $-0.95 | $-0.91 | $-0.60 | $-0.66 | $-0.02 | $-0.30 | $-1.21 | $-0.22 | $-0.89 | $-0.82 | $-2.56 | $-2.27 | $-0.48 | $-0.70 | $-0.64 | $0.08 | $1.01 | $0.24 | $0.27 | $0.00 |